he events of 2020 exemplified the importance of the Environment, Social and Governance (ESG) work done by Johnson & Johnson and the critical need to engage with all of Our Credo stakeholders—including patients, consumers, healthcare providers, business partners, investors and society as a whole. We also wish to deepen our engagement with the investment community by providing an update on company progress on ESG initiatives that aim to advance a healthier world for all.

Grounded in the company’s purpose to blend heart, science and ingenuity to change the trajectory of human health, and guided by Our Credo, the ESG Investor Update Webcast will outline the company’s ESG management approach around its priority topics. In addition to providing detail on Johnson & Johnson’s new set of bold Health for Humanity 2025 Goals, leaders from across the enterprise will share the progress the company has made to help drive long-term value creation and strengthen our ability to respond to the needs and expectations of all stakeholders.